Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10789)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 7, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Renna S, Cottone M, Orlando A. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. World J Gastroenterol 2014; 20(29): 9675-9690 [PMID: 25110407 DOI: 10.3748/wjg.v20.i29.9675] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i29/9675.htm |
| Number | Citing Articles |
| 1 |
Błażej Ochman, Agnieszka Kula, Elżbieta Świętochowska. The functional role of miRNAs in inflammatory pathways associated with intestinal epithelial tight junction barrier regulation in IBD. Postępy Higieny i Medycyny Doświadczalnej 2022; 76(1): 254 doi: 10.2478/ahem-2022-0038
|
| 2 |
Dong Yeon Jeong, Seung Kim, Min Ji Son, Chei Yun Son, Jong Yeob Kim, Andreas Kronbichler, Keum Hwa Lee, Jae Il Shin. Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review. Autoimmunity Reviews 2019; 18(5): 439 doi: 10.1016/j.autrev.2019.03.002
|
| 3 |
Yi-Hao Che, Zheng-Yong Yu, Fu-Neng Geng, Miao He, Zhi-Bin Yang, Yuan-Yuan Zheng, Cheng-Gui Zhang, Yu Zhao, Xiu-Mei Wu, Heng Liu. Effects of the Traditional Chinese Medicine Formula Ento-PB in Experimental Models of Ulcerative Colitis. Natural Product Communications 2022; 17(3) doi: 10.1177/1934578X221078453
|
| 4 |
J.K. Yamamoto-Furusho, A. Sarmiento-Aguilar, N.N. Parra-Holguín, K.E. Bozada-Gutiérrez. Evaluación del esquema de vacunación y cuidados con relación al seguimiento y tratamiento de los pacientes con enfermedad inflamatoria intestinal. Revista de Gastroenterología de México 2019; 84(1): 11 doi: 10.1016/j.rgmx.2018.02.003
|
| 5 |
Yu-Jing Wang, Qiang-Ming Li, Xue-Qiang Zha, Jian-Ping Luo.
Dendrobium fimbriatum Hook polysaccharide ameliorates dextran-sodium-sulfate-induced colitis in mice via improving intestinal barrier function, modulating intestinal microbiota, and reducing oxidative stress and inflammatory responses. Food & Function 2022; 13(1): 143 doi: 10.1039/D1FO03003E
|
| 6 |
Nikoletta Almási, Szilvia Török, Szabolcs Dvorácskó, Csaba Tömböly, Ákos Csonka, Zoltán Baráth, Zsolt Murlasits, Zsuzsanna Valkusz, Anikó Pósa, Csaba Varga, Krisztina Kupai. Lessons on the Sigma-1 Receptor in TNBS-Induced Rat Colitis: Modulation of the UCHL-1, IL-6 Pathway. International Journal of Molecular Sciences 2020; 21(11): 4046 doi: 10.3390/ijms21114046
|
| 7 |
Domenico Corica, Claudio Romano. Renal Involvement in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 2016; 10(2): 226 doi: 10.1093/ecco-jcc/jjv138
|
| 8 |
Qi-yue Yang, Le-le Ma, Chen Zhang, Jun-zhi Lin, Li Han, Ya-nan He, Chun-guang Xie. Exploring the Mechanism of Indigo Naturalis in the Treatment of Ulcerative Colitis Based on TLR4/MyD88/NF-κB Signaling Pathway and Gut Microbiota. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.674416
|
| 9 |
Hasnaa Ali Ebrahim, Dalia Mahmoud Abdelmonem Elsherbini. Renovation of Intestinal Barrier by Polydatin in Experimentally Induced Ulcerative Colitis: Comparative Ultrastructural Study with L-Carnosine. Cells Tissues Organs 2021; 210(4): 275 doi: 10.1159/000516191
|
| 10 |
Yuxin Dai, Peiyi Li, Junyu Zhu, Jiaxin Jiang, weiwei tao, Tong Zhao, Yue Hu, Kang Ding, Min Zhao. Xianglian Pill Attenuates Ulcerative Colitis Through TLR4/MyD88/NF-κB Signaling Pathway. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4167665
|
| 11 |
Gionata Fiorino, Nawal Bent-Ennakhil, Pasquale Varriale, Fiona Braegger, Eveline Hoefkens. Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice Experiment. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae015
|
| 12 |
Ignacio Marin-Jimenez, Guillermo Bastida, Ana Forés, Esther Garcia-Planella, Federico Argüelles-Arias, Pilar Sarasa, Ignacio Tagarro, Alonso Fernández-Nistal, Carmen Montoto, Mariam Aguas, Javier Santos-Fernández, Marta Maia Bosca-Watts, Rocio Ferreiro, Olga Merino, Xavier Aldeguer, Xavier Cortés, Beatriz Sicilia, Francisco Mesonero, Manuel Barreiro-de Acosta. Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study. BMJ Open Gastroenterology 2020; 7(1): e000351 doi: 10.1136/bmjgast-2019-000351
|
| 13 |
Joanne E. Brady, Marni Stott-Miller, George Mu, Sue Perera. Treatment Patterns and Sequencing in Patients With Inflammatory Bowel Disease. Clinical Therapeutics 2018; 40(9): 1509 doi: 10.1016/j.clinthera.2018.07.013
|
| 14 |
Marwa S. Serrya, Ahmed R. El-Sheakh, Mirhan N. Makled. Evaluation of the therapeutic effects of mycophenolate mofetil targeting Nrf-2 and NLRP3 inflammasome in acetic acid induced ulcerative colitis in rats. Life Sciences 2021; 271: 119154 doi: 10.1016/j.lfs.2021.119154
|
| 15 |
Yuqin Liu, Caifang Gao, Gang Li, Zhuangzhuang Niu, Xiaoli Liu, Hao Shen, Jinghua Sun, Ruiping Zhang. Melanin Nanoparticle-Modified Probiotics for Targeted Synergistic Therapy of Ulcerative Colitis. ACS Applied Materials & Interfaces 2024; 16(25): 31950 doi: 10.1021/acsami.4c02914
|
| 16 |
Elif Oguz, Sezen Kocarslan, Suzan Tabur, Hatice Sezen, Zehra Yilmaz, Nurten Aksoy. Effects of Lycopene Alone or Combined with Melatonin on Methotrexate-Induced Nephrotoxicity in Rats. Asian Pacific Journal of Cancer Prevention 2015; 16(14): 6061 doi: 10.7314/APJCP.2015.16.14.6061
|
| 17 |
Larissa S. Celiberto, Franziska A. Graef, Genelle R. Healey, Else S. Bosman, Kevan Jacobson, Laura M. Sly, Bruce A. Vallance. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome. Immunology 2018; 155(1): 36 doi: 10.1111/imm.12939
|
| 18 |
Huashan Liu, Zhenxing Liang, Fengwei Wang, Chi Zhou, Xiaobin Zheng, Tuo Hu, Xiaowen He, Xianrui Wu, Ping Lan. Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI Insight 2019; 4(24) doi: 10.1172/jci.insight.131273
|
| 19 |
Fabio Salvatore Macaluso, Sara Renna, Ambrogio Orlando, Mario Cottone. The biologics of ulcerative colitis. Expert Opinion on Biological Therapy 2017; 17(2): 175 doi: 10.1080/14712598.2017.1271871
|
| 20 |
J.K. Yamamoto-Furusho, A. Sarmiento-Aguilar, N.N. Parra-Holguín, K.E. Bozada-Gutiérrez. Evaluation of a vaccination regimen and care in relation to follow-up and treatment of patients with inflammatory bowel disease. Revista de Gastroenterología de México (English Edition) 2019; 84(1): 11 doi: 10.1016/j.rgmxen.2018.05.001
|
| 21 |
Josip Vrdoljak, Marino Vilović, Piero Marin Živković, Ivana Tadin Hadjina, Doris Rušić, Josipa Bukić, Josip Anđelo Borovac, Joško Božić. Mediterranean Diet Adherence and Dietary Attitudes in Patients with Inflammatory Bowel Disease. Nutrients 2020; 12(11): 3429 doi: 10.3390/nu12113429
|
| 22 |
Si Chu, Ting Yu, Wenzhu Wang, Hui Wu, Feng Zhu, Chunzhu Wei, Fei Gao, Chang Liu, Heng Fan. Exosomes derived from EphB2-overexpressing bone marrow mesenchymal stem cells regulate immune balance and repair barrier function. Biotechnology Letters 2023; 45(5-6): 601 doi: 10.1007/s10529-023-03358-y
|
| 23 |
Chu-Tian Mai, Mei-Mei Wu, Chun-Li Wang, Zi-Ren Su, Yuan-Yuan Cheng, Xiao-Jun Zhang. Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation. Molecular Immunology 2019; 105: 76 doi: 10.1016/j.molimm.2018.10.015
|
| 24 |
Giovanni C Actis. Biologics for Ulcerative Colitis: Status of the Art and General Considerations. Annals of Colorectal Research 2016; (Inpress) doi: 10.17795/acr-42868
|
| 25 |
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology 2018; 113(4): 481 doi: 10.1038/ajg.2018.27
|
| 26 |
Giorgia Bodini, Claudia Zanella, Mattia Crespi, Sara Lo Pumo, Maria Giulia Demarzo, Edoardo Savarino, Vincenzo Savarino, Edoardo G. Giannini. A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease. Nutrition 2019; : 110542 doi: 10.1016/j.nut.2019.06.023
|
| 27 |
Geonhee Han, Haeun Cho, Hyosuk Kim, Yeongji Jang, Hochung Jang, Da Eun Kim, Eun Sun Kim, Eun Hye Kim, Kwang Yeon Hwang, Kwangmeyung Kim, Yoosoo Yang, Sun Hwa Kim. Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress. Biomaterials Science 2022; 10(8): 2076 doi: 10.1039/D1BM01797G
|
| 28 |
Qing Guo, Yizi Jin, Xinyu Chen, Xiaomin Ye, Xin Shen, Mingxi Lin, Cheng Zeng, Teng Zhou, Jian Zhang. NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01757-9
|
| 29 |
Carlos Fernandes, Mariangela Allocca, Silvio Danese, Gionata Fiorino. Progress With Anti-Tumor Necrosis Factor Therapeutics for the Treatment of Inflammatory Bowel Disease. Immunotherapy 2015; 7(2): 175 doi: 10.2217/imt.14.105
|
| 30 |
Marie Muller, Julien Broséus, Pierre Feugier, Catherine Thieblemont, Laurent Beaugerie, Silvio Danese, Djésia Arnone, Ndeye Coumba Ndiaye, Tunay Kokten, Rémi Houlgatte, Laurent Peyrin-Biroulet. Characteristics of Lymphoma in Patients with Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn's and Colitis 2021; 15(5): 827 doi: 10.1093/ecco-jcc/jjaa193
|
| 31 |
Naoto Saigusa, Jun-ichi Saigusa, Masaru Shinozaki, Tadashi Yokoyama, Yoshihiro Yokoi, Hideki Takami, Ryoji Miyahara, Yasuhisa Yokoyama. A series of seton techniques involving "top-down therapy" for patients with Crohn's disease who initially presented with perianal fistulas. Journal of the Anus, Rectum and Colon 2018; 2(4): 122 doi: 10.23922/jarc.2017-044
|
| 32 |
Juanjuan Li, Weiliang Hou, Sisi Lin, Lu Wang, Chao Pan, Feng Wu, Jinyao Liu. Polydopamine Nanoparticle‐Mediated Dopaminergic Immunoregulation in Colitis. Advanced Science 2022; 9(1) doi: 10.1002/advs.202104006
|
| 33 |
Liza Vecchi Brumatti, Annalisa Marcuzzi, Paola Tricarico, Valentina Zanin, Martina Girardelli, Anna Bianco. Curcumin and Inflammatory Bowel Disease: Potential and Limits of Innovative Treatments. Molecules 2014; 19(12): 21127 doi: 10.3390/molecules191221127
|
| 34 |
Yiqi Xu, Chengyuan Lin, Hor-Yue Tan, Zhao-xiang Bian. The double-edged sword effect of indigo naturalis. Food and Chemical Toxicology 2024; 185: 114476 doi: 10.1016/j.fct.2024.114476
|
| 35 |
Dong Wook Shin, Beong Ou Lim. Nutritional Interventions Using Functional Foods and Nutraceuticals to Improve Inflammatory Bowel Disease. Journal of Medicinal Food 2020; 23(11): 1136 doi: 10.1089/jmf.2020.4712
|
| 36 |
Ilker Ozgur, Cemil Burak Kulle, Melek Buyuk, Asli Ormeci, Filiz Akyuz, Emre Balik, Turker Bulut, Metin Keskin. What are the predictors for recurrence of Crohn's disease after surgery?. Medicine 2021; 100(14): e25340 doi: 10.1097/MD.0000000000025340
|
| 37 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 38 |
Payaswini Vasanth, Michelle Parmley, Jose Torrealba, Tamim Hamdi. Interstitial Nephritis in a Patient with Inflammatory Bowel Disease. Case Reports in Nephrology 2016; 2016: 1 doi: 10.1155/2016/4260365
|
| 39 |
Herve Courthion, Thibault Mugnier, Christel Rousseaux, Michael Möller, Robert Gurny, Doris Gabriel. Self-assembling polymeric nanocarriers to target inflammatory lesions in ulcerative colitis. Journal of Controlled Release 2018; 275: 32 doi: 10.1016/j.jconrel.2017.07.044
|
| 40 |
Giovanni Mazzola, Fabio Salvatore Macaluso, Lucia Adamoli, Sara Renna, Antonio Cascio, Ambrogio Orlando. Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease. Journal of Infection 2017; 74(5): 433 doi: 10.1016/j.jinf.2017.02.009
|
| 41 |
Xuewei Ma, Yichen Hu, Xin Li, Xiaoting Zheng, Yitao Wang, Jinming Zhang, Chaomei Fu, Funeng Geng. Periplaneta americana Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats by Keap1/Nrf-2 Activation, Intestinal Barrier Function, and Gut Microbiota Regulation. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00944
|
| 42 |
Adam Joseph Hardy, Ionica Stoica, David Edward Kearney, Diarmuid S O'Riordain. Diffuse large B-cell lymphoma of the rectum in a patient with Crohn’s disease. BMJ Case Reports 2020; 13(4): e228818 doi: 10.1136/bcr-2018-228818
|
| 43 |
Leena Amine, Ibtihal S Abdelgadir, Karen Neves, Mamoun Elawad, Amel Hassan, Anthony K Akobeng. Tacrolimus for induction therapy in active Crohn's disease. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013142
|
| 44 |
Fabio Salvatore Macaluso, Marcello Maida, Sara Renna, Emanuele Orlando, Marco Affronti, Chiara Sapienza, Mariangela Dimarco, Rosalba Orlando, Giulia Rizzuto, Mario Cottone, Ambrogio Orlando. Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants. Digestive and Liver Disease 2017; 49(2): 157 doi: 10.1016/j.dld.2016.10.001
|
| 45 |
Jing-Jing Wang, Yi-Hong Fan. Advances in research of tacrolimus for treatment of inflammatory bowel disease. World Chinese Journal of Digestology 2019; 27(13): 842 doi: 10.11569/wcjd.v27.i13.842
|
| 46 |
Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chian Lim, Wai Keung Leung, Raja Affendi Raja Ali, Deng Chyang Wu, Evan Ong, Nazri Mustaffa, Julajak Limsrivilai, Tadakazu Hisamatsu, Suk Kyun Yang, Qin Ouyang, Richard Geary, Janaka H De Silva, Rungsun Rerknimitr, Marcellus Simadibrata, Murdani Abdullah, Rupert WL Leong. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia. Intestinal Research 2019; 17(3): 285 doi: 10.5217/ir.2019.00026
|
| 47 |
Giovanni C Actis. Biologics for Ulcerative Colitis: Status of the Art and General Considerations. Annals of Colorectal Research 2016; 5(1) doi: 10.5812/acr.42868
|
| 48 |
J. Clowry, J. Sheridan, R. Healy, S. Deady, D. Keegan, K. Byrne, G. Cullen, H. Mulcahy, H. Comber, A.C. Parnell, G. Doherty, A. Lally. Increased non‐melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single‐centre cohort study. Journal of the European Academy of Dermatology and Venereology 2017; 31(6): 978 doi: 10.1111/jdv.14105
|
| 49 |
Wan-Rong Dong, Yao-Yao Li, Tian-Tian Liu, Gao Zhou, Yu-Xin Chen. Ethyl acetate extract of Terminalia chebula alleviates DSS-induced ulcerative colitis in C57BL/6 mice. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1229772
|
| 50 |
Naoto Saigusa, Jun-ichi Saigusa, Tadashi Yokoyama, Takaaki Oosawa, Seiji Ishiguro, Masaru Shinozaki, Manabu Kikuchi, Yasuhisa Yokoyama. “Top Down Therapy” for Patients with Crohn's Disease who Initially Presented with Anorectal Fistula May Improve Perianal and Bowel Disease. Nippon Daicho Komonbyo Gakkai Zasshi 2016; 69(8): 424 doi: 10.3862/jcoloproctology.69.424
|
| 51 |
Mohammad Al Mijan, Beong Ou Lim. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends. World Journal of Gastroenterology 2018; 24(25): 2673-2685 doi: 10.3748/wjg.v24.i25.2673
|
| 52 |
Xianghua Guo, Runhua Guo, Xia Luo, Lian Zhou. Ethyl pyruvate ameliorates experimental colitis in mice by inhibiting the HMGB1-Th17 and Th1/Tc1 responses. International Immunopharmacology 2015; 29(2): 454 doi: 10.1016/j.intimp.2015.10.015
|
| 53 |
Madeleen Bosma, Marco Gerling, Jenny Pasto, Anastasia Georgiadi, Evan Graham, Olga Shilkova, Yasunori Iwata, Sven Almer, Jan Söderman, Rune Toftgård, Fredrik Wermeling, Elisabeth Almer Boström, Pontus Almer Boström. FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice. Nature Communications 2016; 7(1) doi: 10.1038/ncomms11314
|
| 54 |
TOMOYUKI NAKANE, KEIICHI MITSUYAMA, RYOSUKE YAMAUCHI, TATSUYUKI KAKUMA, TAKUJI TORIMURA. Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review. The Kurume Medical Journal 2021; 68(2): 43 doi: 10.2739/kurumemedj.MS682006
|
| 55 |
Yueying Chen, Jun Shen. Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review. eClinicalMedicine 2022; 46: 101382 doi: 10.1016/j.eclinm.2022.101382
|
| 56 |
Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, Anna Viola, Maria Cappello, Barbara Scrivo, Antonio Magnano, Dario Pluchino, Salvatore Camilleri, Serena Garufi, Roberto Di Mitri, Filippo Mocciaro, Giovanni Magrì, Concetta Ferracane, Michele Citrano, Francesco Graziano, Carmelo Bertolami, Sara Renna, Rosalba Orlando, Giulia Rizzuto, Mario Cottone, Ambrogio Orlando. A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis. Digestive and Liver Disease 2020; 52(12): 1461 doi: 10.1016/j.dld.2020.06.014
|
| 57 |
Jisu Kim, Shuya Zhang, Ying Zhu, Ruirui Wang, Jianxin Wang. Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines. Journal of Ginseng Research 2023; 47(5): 627 doi: 10.1016/j.jgr.2023.01.004
|
| 58 |
Huikang Xu, Jiamin Fu, Lijun Chen, Sining Zhou, Yangxin Fang, Qi Zhang, Xin Chen, Li Yuan, Yifei Li, Zhenyu Xu, Charlie Xiang, Tianxiao Zhang. TNF-α Enhances the Therapeutic Effects of MenSC-Derived Small Extracellular Vesicles on Inflammatory Bowel Disease through Macrophage Polarization by miR-24-3p. Stem Cells International 2023; 2023: 1 doi: 10.1155/2023/2988907
|
| 59 |
Kazuya Kishimoto, Yuji Nozaki, Toshiharu Sakurai, Koji Kinoshita, Masanori Funauchi, Itaru Matsumura. Takayasu’s Arteritis Diagnosed in an Adolescent Patient with Crohn’s Disease: Management of Biologicals. Life 2021; 11(10): 1019 doi: 10.3390/life11101019
|
| 60 |
Yuxin Dai, Qiulu Lu, Peiyi Li, Junyu Zhu, Jiaxin Jiang, Tong Zhao, Yue Hu, Kang Ding, Min Zhao. Xianglian Pill attenuates ulcerative colitis through TLR4/MyD88/NF-κB signaling pathway. Journal of Ethnopharmacology 2023; 300: 115690 doi: 10.1016/j.jep.2022.115690
|
| 61 |
Si Chu, Ting Yu, Wenzhu Wang, Hui Wu, Xingxing Liu, Feng Zhu, Chunzhu Wei, Fei Gao, Chang Liu, Heng Fan. Exosomes Derived from EphB2-Overexpressing Bone Marrow Mesenchymal Stem Cells Regulate Immune Balance and Repair Barrier Function <i> in vitro</i>. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3943530
|
| 62 |
Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chian Lim, Wai Keung Leung, Raja Affendi Raja Ali, Deng Chyang Wu, Evan Ong, Nazri Mustaffa, Julajak Limsrivilai, Tadakazu Hisamatsu, Suk Kyun Yang, Qin Ouyang, Richard Geary, Janaka H De Silva, Rungsun Rerknimitr, Marcellus Simadibrata, Murdani Abdullah, Rupert W L Leong. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia. Journal of Gastroenterology and Hepatology 2019; 34(8): 1296 doi: 10.1111/jgh.14648
|
| 63 |
Makoto Naganuma, Kenji Watanabe, Satoshi Motoya, Haruhiko Ogata, Toshiyuki Matsui, Yasuo Suzuki, Lyann Ursos, Shigeru Sakamoto, Mitsuhiro Shikamura, Tetsuharu Hori, Jovelle Fernandez, Mamoru Watanabe, Toshifumi Hibi, Takanori Kanai. Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis. Journal of Gastroenterology and Hepatology 2022; 37(1): 81 doi: 10.1111/jgh.15667
|
| 64 |
Chenxi Feng, Jinhua Yan, Ting Luo, Hong Zhang, Hu Zhang, Yu Yuan, Yi Chen, Haiyang Chen. Vitamin B12 ameliorates gut epithelial injury via modulating the HIF-1 pathway and gut microbiota. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05435-5
|
| 65 |
M Larche, D McGonagle. A case of resistant spondyloarthritis (SpA) that responded to tacrolimus and mycophenolate treatment initiated at the time of renal transplantation for unrelated renal failure. Scandinavian Journal of Rheumatology 2017; 46(2): 158 doi: 10.3109/03009742.2016.1148774
|
| 66 |
Lívia Medeiros Soares Celani, Eryvaldo Sócrates Tabosa Egito, Ítalo Medeiros Azevedo, Cláudia Nunes Oliveira, Douglas Dourado, Aldo Cunha Medeiros. Treatment of colitis by oral negatively charged nanostructured curcumin in rats. Acta Cirúrgica Brasileira 2022; 37(6) doi: 10.1590/acb370602
|
| 67 |
Sophia Junker, Oliver Ebert, Robert Bartsch. A Systematic Literature Review of Injection Site Pain Perception in Adult
Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents. Current Rheumatology Reviews 2023; 19(3): 303 doi: 10.2174/1573397118666220829123713
|
| 68 |
Shulin Wei, Mingxing Li, Qin Wang, Yueshui Zhao, Fukuan Du, Yu Chen, Shuai Deng, Jing Shen, Ke Wu, Jiayue Yang, Yuhong Sun, Li Gu, Xiaobing Li, Wanping Li, Meijuan Chen, Xiao Ling, Lei Yu, Zhangang Xiao, Lishu Dong, Xu Wu. Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease. Journal of Inflammation Research 2024; : 3307 doi: 10.2147/JIR.S458103
|
| 69 |
Xiaoyi Liu, Mingjun Zhang, Shuai Chen, Huijuan Liu, Haoran Ma, Ting Hu, Peng Luo, Shaofeng Wei. Grifola frondosa polysaccharide's therapeutic potential in oxazolone-induced ulcerative colitis. Carbohydrate Polymers 2024; 344: 122517 doi: 10.1016/j.carbpol.2024.122517
|